Author Correction: 1-Phenyl-β-carboline-3-carboxamide-1,2,3-triazole-N-phenylacetamide hybrids as new α-glucosidase inhibitors
Saved in:
| Main Authors: | Elham Safaie, Mohammad Hosein Sayahi, Navid Dastyafteh, Mohammad Halimi, Milad Noori, Maryam Mohammadi-Khanaposhtani, Afsaneh Zonouzi, Roghieh Mirzazadeh, Azadeh Tajmir-Riahi, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Bagher Larijani, Mehdi Asadi, Mohammad Mahdavi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-08983-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
1-Phenyl-β-carboline-3-carboxamide-1,2,3-triazole-N-phenylacetamide hybrids as new α-glucosidase inhibitors
by: Elham Safaie, et al.
Published: (2025-05-01) -
Rational design, synthesis, in vitro, and in-silico studies of pyrazole‑phthalazine hybrids as new α‑glucosidase inhibitors
by: Mehrdad Roshan, et al.
Published: (2025-01-01) -
Design, synthesis, and anti-urease evaluations of new sulfonamide-1,2,3-triazole-acetamide derivatives
by: Shohreh Bakhshi Varzaneh, et al.
Published: (2025-07-01) -
Solvatochromism of N-aryl-phenylacetamides
by: Suzana Lj. Apostolov, et al.
Published: (2016-06-01) -
Substituted piperazine conjugated to quinoline-thiosemicarbazide as potent α-glucosidase inhibitors to target hyperglycemia
by: Mehran Ghasemi, et al.
Published: (2025-01-01)